Sodium Nitroprusside Injection
Product Images NDC 55150-320

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Nitroprusside (NDC 55150-320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metabolism Of Sodium Nitroprusside (Sodiumnitro Fig1)

The text appears to be a chemical reaction pathway describing the metabolism of sodium nitroprusside. It involves the conversion of sodium nitroprusside to methemoglobin through interaction with cytochromes, followed by further metabolic conversions resulting in the formation of thiocyanate and cyanmethemoglobin. The reaction also involves the use of thiosulfate and rhodanase as metabolic intermediaries.*

FDA Label Image

Package Label-principal Display Panel (50 mg/2 mL (25 mg/mL))

This is a description for a medication with the NDC 55150-320-01, containing Nitroprusside Sodium. The medication is manufactured in India by AuroMedics Pharma LLC, and is meant for intravenous infusion only. The medication comes in a single-dose vial of 2mL, with a concentration of 50mg/2mL (25mg/mL). The text also advises to protect the medication from light, and to monitor blood pressure before and during administration. The expiration date is not provided.*

FDA Label Image

Package Label-principal Display Panel (50 mg/2 mL (25 mg/mL))

This is a medication called Sodium Nitroprusside Injection, with an area called "Unvarnished Zone" measuring 35 x 35 mm, to be dilute for intravenous infusion only, used for monitoring blood pressure before and during administration. The medication comes in a 2 mL single-dose vial that must be discarded 24 hours after dilution. The medication must be protected from light and the stopper is not made with natural rubber latex. See the package insert for dilution instructions and to get more information about the medication. It is distributed by AuroMedics Pharma LLG located at 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520 and made in India.*

FDA Label Image

Package Label-principal Display Panel (50 mg per 2 mL (25 mg / mL) – Light Protective Sleeve)

This is a description for a medication called Sodium Nitroprusside. It is an infusion that should be protected from light by covering it with a protective sleeve or other opaque material. It is diluted in 5% Dextrose Injection, USP with a specific date and time for dilution and expiration. The solution should be discarded 24 hours after dilution, and no other medications should be added to it. The enclosure provides instructions for use. The medication is distributed by AuroMedics Pharma LLC and made in India with the code TS/DRUGS/13/2010.*

FDA Label Image

Package Label-principal Display Panel (Carton of Light Protective Sleeve)

This is a product that includes a light protective sleeve for Sodium Nitroprusside infusion solution. The sleeve is designed to protect the infusion from light and can be used with other opaque materials. The product was made in India for AuroMedics Pharma LLC.*

FDA Label Image

Chemical Structure (Sodiumnitro Str)

Sodium Nitroprusside is a chemical compound commonly used as a medication to lower blood pressure during surgery or to treat hypertensive crises.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.